Status:

COMPLETED

Atalante USAbility

Lead Sponsor:

Wandercraft

Collaborating Sponsors:

Innovative Medical Technologies, Inc

Shirley Ryan AbilityLab

Conditions:

Hemiplegia

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The "USAbility" study - Human Factor Validation Testing of the Atalante exoskeleton aims at demonstrating that Atalante can be used by the intended users without serious use errors or problems, for th...

Detailed Description

Robotic assisted rehabilitation has been successfully proposed and employed especially when motor conditions do not allow the patient to walk. However, limitations in usability often prevent from a wi...

Eligibility Criteria

Inclusion

  • Operators\*
  • Operators belonging to one of the following categories:
  • Physiotherapists
  • Physiotherapist assistants
  • Exercise physiologists
  • Rehabilitation technicians
  • Operators are US residents
  • Operators can speak, write, and understand English
  • Need for supervision for specific operators' categories is regulated by the specific state laws and jurisdiction and is part of the responsibility of the healthcare facility.
  • Patients:
  • Aged 18 and over
  • More than 30 days post stroke
  • English speakers: able to read, understand, and sign the informed consent
  • With specific morphological characteristics

Exclusion

  • Patients:
  • Individuals with severe spasticity of adductor muscles, hamstring, quadriceps, and triceps surrae. Severe spasticity is defined by a score greater than 3 on the modified Ashworth scale
  • Pregnant women
  • History(ies) of osteoporotic fracture(s) and/or treatment causing secondary osteoporosis
  • Pressure Ulcer of Grade I or higher according to the NPUAP International Pressure Ulcer Classification System - EPUAP, in areas of contact with the Atalante system
  • Cognitive impairment that prevents the patient from understanding instructions, at the physician's discretion

Key Trial Info

Start Date :

November 29 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 10 2022

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT05284708

Start Date

November 29 2021

End Date

January 10 2022

Last Update

March 17 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Shirley Ryan AbilityLab

Chicago, Illinois, United States, 60611